|
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
1 |
[GO] |
2023―Nov―24 |
Platelet dropping, bleeding and new treatment requirements in ITP patients after inactivated COVID-19 vaccination |
Xiao-Yong Zhan, Hui Chen, Huimin Kong, Tongfei Meng, Jieyu Ye, Yong Liu, et al. (+8) Margaret H.L. Ng, Liang Li, Yuming Zhang, Jinqi Huang, Qiang Peng, Chun Chen, Yulong He, Mo Yang |
2 |
[GO] |
2023―Sep―06 |
USE OF RECOMBINANT S1 PROTEIN WITH hFc FOR ANALYSIS OF SARS-COV-2 ADSORPTION AND EVALUATION OF DRUGS THAT INHIBIT ENTRY INTO VERO E6 CELLS |
Jéssica Carla Martins Couto, Taís Vidal, Eduardo Reichert Decker, Janio M Santurio, Carlos Fernando de Mello, Micheli Mainardi Pillat |
3 |
[GO] |
2023―Aug―18 |
Pre-infection antibody levels of vaccinated healthcare workers with SARS-CoV-2 breakthrough infection: A nested case-control study |
Sema Alp Çavuş, Muammer Çelik, Ahmet Furkan Süner, Irmak Güzel, Çağlar Irmak, Derya Çağlayan, et al. (+9) Huriye Gamze Öztürk, Neslişah Şiyve, Özgür Appak, Elif Işık, Gül Ergör, Osman Alparslan Ergör, Yücel Demiral, Ayça Arzu Sayıner, Bülent Kılıç |
4 |
[GO] |
2023―Jun―18 |
Serum profiles of pro-inflammatory and anti-inflammatory cytokines in non-hospitalized patients with mild/moderate COVID-19 infection. |
Abdulraheem Y. Majeed, Nor Effa S. Zulkafli, Ali H. Ad'hiah |
5 |
[GO] |
2023―Jun―03 |
Myocarditis Development After COVID-19 Vaccination in an Immunodeficient Case |
Öner Özdemir, Elif Şeker, Ümmügülsüm Dikici, Muhammed Güneş |
6 |
[GO] |
2023―Mai―24 |
Inactivated COVID-19 vaccines: potential concerns of antibody-dependent enhancement and original antigenic sin |
Andy Ka Chun Kan, Philip Hei Li |
7 |
[GO] |
2023―Jan―23 |
Immunothrombosis biomarkers as potential predictive factors of acute respiratory distress syndrome in moderate-to-critical COVID-19: a single-center, retrospective cohort study |
Giou-Teng Yiang, Yao-Kuang Wu, Kuo-Wang Tsai, I-Shiang Tzeng, Wan-Chung Hu, Min-Tser Liao, et al. (+4) Kuo-Cheng Lu, Hsueh-Wen Chung, You-Chen Chao, Wen-Lin Su |
8 |
[GO] |
2023―Jan―02 |
Does infection with Leishmania protect against Covid-19? |
Nasreddine Saidi, Refka Jelassi |
9 |
[GO] |
2022―Nov―13 |
COVID-19 Acute Respiratory Distress Syndrome promotes a specific alternative macrophage polarization |
Marc Garnier, Florian Blanchard, Arnaud Mailleux, Laurence Morand-Joubert, Bruno Crestani, Christophe Quesnel |
10 |
[GO] |
2022―Okt―21 |
Comparison of three different COVID-19 vaccine platforms (CoronaVac, BTN162b2, and Ad5-nCoV) in individuals with and without prior COVID-19: Reactogenicity and neutralizing antibodies |
José Javier Morales-Núñez, José Francisco Muñoz-Valle, Andrea Carolina Machado-Sulbarán, Saúl Alberto Díaz-Pérez, Paola Carolina Torres-Hernández, Beatriz Verónica Panduro-Espinoza, et al. (+3) Jonathan Adrián Gallegos-Díaz de Leon, Carlos David Munguía-Ramirez, Jorge Hernández-Bello |
11 |
[GO] |
2022―Sep―27 |
SARS-CoV-2-specicific humoral immunity in convalescent patients with mild COVID-19 is supported by CD4+ T-cell help and negatively correlated with Alphacoronavirus-specific antibody titer |
Marcus Odendahl, Iris Endler, Beate Haubold, Roman N. Rodionov, Stefan R. Bornstein, Torsten Tonn |
12 |
[GO] |
2022―Sep―27 |
Immune, inflammatory and prothrombotic parameters in COVID-19 patients treated with an anti EGFR antibody. |
Danay Saavedra, Ana L. Añé-Kourí, Egda M. Llanez Gregorich, Jilma Mena, Patricia Lorenzo-Luaces, Henrry Diaz Londres, et al. (+8) Aray Hernández Martinez, Jorge Jiménez Armada, Yamilka Hernández Sánchez, Yaneth Zamora González, Mayelin Troche, Loipa Medel, Mayra Ramos, Tania Crombet |
13 |
[GO] |
2022―Sep―13 |
Full seroconversion in initial non-responders with higher antibody levels after heterologous COVID-19 vaccination schedule. |
Wagner Angelika, Anna Ohradanova-Repic, Laura Gebetsberger, Gabor Tajti, Kundi Michael, Stockinger Hannes, et al. (+2) Ursula Wiedermann, Grabmeier-Pfistershammer Katharina |
14 |
[GO] |
2022―Aug―31 |
Novel skewed usage of B-cell receptors in COVID-19 patients with various clinical presentations |
Junpeng Ma, Han Bai, Tian Gong, Weikang Mao, Yijun Nie, Xuan Zhang, et al. (+8) Yanyan Da, Xiaorui Wang, Hongyu Qin, Qiqi Zeng, Fang Hu, Xin Qi, Bingyin Shi, Chengsheng Zhang |
15 |
[GO] |
2022―Jul―14 |
Diminished T-cell Immune Responses to SARS-CoV-2 Omicron Variant after BNT162b2 Vaccination |
Stanley C. Jordan, Bong-Ha Shin, Edgar Rodriguez, Vo Ashley, Ruan Zhang |
16 |
[GO] |
2022―Jul―08 |
Soluble CD137 as a potential biomarker for severe COVID-19 |
Mariana de Oliveira Marques, André Abdo, Priscilla Brito Silva, Amilton Silva Junior, Lucas Bassolli de Oliveira Alves, José Victor Gomes Costa, et al. (+3) Josiane Martin, Philip Bachour, Otavio C.G. Baiocchi |
17 |
[GO] |
2022―Mai―31 |
Could anti-ACE2 antibodies alter the results of SARS-CoV-2 Ab neutralization assays? |
Raquel Tobes |
18 |
[GO] |
2022―Feb―04 |
A tabulated summary of the evidence on humoral and cellular responses to the SARS-CoV-2 Omicron VOC, as well as vaccine efficacy against this variant. |
S.O Minka, F.H Minka |
19 |
[GO] |
2022―Jan―31 |
Immune system aging and the aging-related diseases in the COVID-19 era |
Jacek M. Witkowski |
20 |
[GO] |
2022―Jan―07 |
A novel antibody against the furin cleavage site of SARS-CoV-2 spike protein: effects on proteolytic cleavage and ACE2 binding |
Michael G. Spelios, Jeanne M. Capanelli, Adam W. Li |
21 |
[GO] |
2021―Sep―23 |
Targeting the PI3K/Akt/mTOR pathway: A therapeutic strategy in COVID-19 patients |
Rasha Abu-Eid, Frank James Ward |
22 |
[GO] |
2021―Jul―03 |
SARS-CoV-2 Spike protein enhances ACE2 expression via facilitating Interferon effects in bronchial epithelium |
Ye Zhou, Mu Wang, Yunhui Li, Peihui Wang, Ping Zhao, Zixuan Yang, et al. (+8) Suyuan Wang, Liyuan Zhang, Zhenyang Li, Kaiwei Jia, Cuiping Zhong, Nan Li, Yizhi Yu, Jin Hou |
23 |
[GO] |
2021―Apr―24 |
Will a little change do you good? A putative role of polymorphisms in COVID-19 |
Adriana Alves Oliveira Paim, Ágata Lopes-Ribeiro, Daniele S.O. Daian e Silva, Luis Adan F. Andrade, Thais F. S Moraes, Edel F. Barbosa-Stancioli, et al. (+2) Flávio Guimarães da Fonseca, Jordana G. Coelho-dos-Reis |
24 |
[GO] |
2021―Apr―24 |
HLA-C*17 in COVID-19 patients: hints for associations with severe clinical outcome and cardiovascular risk |
Irene Bonaccorsi, Paolo Carrega, Emmanuele Venanzi Rullo, Rosaria Ducatelli, Michela Falco, Josè Freni, et al. (+8) Massimiliano Miceli, Riccardo Cavaliere, Vincenzo Fontana, Antonio Versace, Gaetano Caramori, Antonio David, Giuseppe Nunnari, Guido Ferlazzo |
25 |
[GO] |
2021―Feb―10 |
Influence of aging on T cell response and renin-angiotensin system imbalance during SARS-CoV-2 infection |
Jorge Quarleri, Cintia Cevallos, M. Victoria Delpino |
26 |
[GO] |
2021―Jan―11 |
Did we forget the diffuse chemosensory system when studying COVID-19? |
Sheila Veronese, Flavia Merigo, Andrea Sbarbati |
27 |
[GO] |
2021―Jan―08 |
Immune reactivity during COVID-19: Implications for treatment |
Claudio Napoli, Giuditta Benincasa, Clelia Criscuolo, Mario Faenza, Cinzia Liberato, Mariangela Rusciano |
28 |
[GO] |
2021―Jan―02 |
Are the emerging SARS-COV-2 mutations friend or foe? |
Adnan Ero |
29 |
[GO] |
2020―Nov―05 |
Pulmonary vascular improvement in severe COVID-19 patients treated with tocilizumab |
Lorenzo Salvati, Mariaelena Occhipinti, Leonardo Gori, Luca Ciani, Alessio Mazzoni, Laura Maggi, et al. (+7) Manuela Capone, Paola Parronchi, Francesco Liotta, Vittorio Miele, Francesco Annunziato, Federico Lavorini, Lorenzo Cosmi |
30 |
[GO] |
2020―Sep―29 |
“Cytokine storm”, not only in COVID-19 patients. Mini-review |
Norbert Lukan |
31 |
[GO] |
2020―Jul―10 |
Intermittent fasting, a possible priming tool for host defense against SARS-CoV-2 infection: crosstalk among calorie restriction, autophagy and immune response |
Md. Abdul Hannan, Md. Ataur Rahman, Md Saidur Rahman, Abdullah Al Mamun Sohag, Raju Dash, Khandkar Shaharina Hossain, et al. (+2) Mithila Farjana, Md Jamal Uddin |
32 |
[GO] |
2020―Jun―20 |
Lymphopenia during the COVID-19 infection: What it shows and what can be learned |
Soheil Tavakolpour, Taha Rakhshandehroo, Erin X. Wei, Mohammad Rashidian |
33 |
[GO] |
2020―Jun―11 |
Sequence homology between human PARP14 and the SARS-CoV-2 ADP ribose 1’-phosphatase |
E. Thomas, Ramy Saad |
34 |
[GO] |
2020―Jun―06 |
How nicotine can inhibit cytokine storm in the lungs and prevent or lessen the severity of COVID-19 infection? |
Malgorzata Kloc, Rafik M. Ghobrial, Jacek Z Kubiak |
35 |
[GO] |
2020―Mai―28 |
Are there any association between COVID-19 severity and immunosuppressive therapy? |
Ahmad Hormati, Mohammad Reza Ghadir, Farhad Zamani, Javad Khodadadi, Fatemeh Khodadust, Mahboubeh Afifian, et al. (+2) Reza Aminnejad, Sajjad Ahmadpour |